Pancreatic Cancer Research

ResearcherUniversity of LiverpoolActive in the last 2 years

Luke Dickerson

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6281-8658; OpenAlex author ID A5022242565. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

  1. Neoadjuvant treatment versus upfront surgery in borderline resectable and resectable pancreatic ductal adenocarcinoma: meta-analysis. Co-author DOI 10.1093/bjsopen/zrae172↗
  2. Differentiation of Autoimmune Pancreatitis from Pancreatic Cancer Remains Challenging. Co-author DOI 10.1007/s00268-019-04928-w↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Paula Ghaneh · 2 shared papers, 2019–2025 · strength 0.34
  2. Michael C. Schmid · 1 shared paper, 2025 · strength 0.26
  3. Ainhoa Mielgo · 1 shared paper, 2025 · strength 0.26
  4. Christopher Michael Halloran · 1 shared paper, 2025 · strength 0.26
  5. Daniel H. Palmer · 1 shared paper, 2025 · strength 0.26
  6. Vincent S. K. Yip · 1 shared paper, 2019 · strength 0.08
  7. John P. Neoptolemos · 1 shared paper, 2019 · strength 0.08
  8. Jorg H. Kleeff · 1 shared paper, 2019 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.